Aurora Cannabis Inc. announced currently that the organization has signed a binding share obtain agreement whereby Aurora has acquired all of the issued and outstanding widespread shares of privately-held Chemi Pharmaceutical Inc, an Ontario-primarily based laboratory specialized in giving higher high quality analytics solutions to the pharmaceutical and cannabis industries, in a money and share transaction comprised of an undisclosed money payment and share consideration of 83,299 shares paid on closing and 41,649 payable upon achievement of particular Chemi milestones.

Strategic Rationale

Chemi has a Well being Canada Drug Establishment Licence enabling them to execute certified GMP compliant high quality handle analytical testing. In addition, Chemi has received US FDA accreditation for their facility, which is the gold normal for worldwide pharmaceutical testing. Acquiring Chemi with their Drug Establishment Licence delivers a important prerequisite for applying for a Cannabis Drug Licence, which is expected for the improvement of cannabis therapies inside the worldwide healthcare cannabis industry.

Strategically positioned adjacent to Pearson Airport in Mississauga, Ontario, Chemi delivers specialized cannabis testing across a broad set of parameters, which includes cannabinoid and terpene content material. Chemi will be integrated into the Company’s wholly owned subsidiary, Anandia Laboratories Inc. (

View the Original write-up